人福医药：宜昌产投集团合计控制公司12.35%表决权股份

格隆汇资讯12-12

格隆汇12月12日丨人福医药(600079.SH)公布，本次权益变动为公司5%以上非第一大股东宜昌产投控股集团有限公司（简称“宜昌产投集团”）全资子公司宜昌产投产业研究发展有限公司（简称“产业研究公司”）与鑫盛利保股权投资有限公司（简称“鑫盛利保”）、中国信达资产管理股份有限公司（简称“中国信达”）及宜昌高新资本投资管理有限公司（简称“宜昌高新资本”）签署《芜湖信福股权投资合伙企业（有限合伙）合伙...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2490388358?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-12-12 19:22","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2490388358","market":"sh","top_or_hot":-1,"title":"人福医药：宜昌产投集团合计控制公司12.35%表决权股份","media":"格隆汇资讯","content":"<div>\n<p>格隆汇12月12日丨人福医药(600079.SH)公布，本次权益变动为公司5%以上非第一大股东宜昌产投控股集团有限公司（简称“宜昌产投集团”）全资子公司宜昌产投产业研究发展有限公司（简称“产业研究公司”）与鑫盛利保股权投资有限公司（简称“鑫盛利保”）、中国信达资产管理股份有限公司（简称“中国信达”）及宜昌高新资本投资管理有限公司（简称“宜昌高新资本”）签署《芜湖信福股权投资合伙企业（有限合伙）合伙...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212192248ab72462b&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>人福医药：宜昌产投集团合计控制公司12.35%表决权股份</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n人福医药：宜昌产投集团合计控制公司12.35%表决权股份\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-12 19:22 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212192248ab72462b&s=b><strong>格隆汇资讯</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>格隆汇12月12日丨人福医药(600079.SH)公布，本次权益变动为公司5%以上非第一大股东宜昌产投控股集团有限公司（简称“宜昌产投集团”）全资子公司宜昌产投产业研究发展有限公司（简称“产业研究公司”）与鑫盛利保股权投资有限公司（简称“鑫盛利保”）、中国信达资产管理股份有限公司（简称“中国信达”）及宜昌高新资本投资管理有限公司（简称“宜昌高新资本”）签署《芜湖信福股权投资合伙企业（有限合伙）合伙...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212192248ab72462b&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0185","symbol_name":"二线龙头","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212192248ab72462b&s=b","article_id":"2490388358","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212192248ab72462b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2490388358","pubTimestamp":1734002561,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"宜昌产投集团通过芜湖信福股权投资合伙企业间接持有公司59,829,636股股份所对应的表决权，占公司有表决权股份总数的3.67%。本次权益变动后，宜昌产投集团合计控制公司201,597,643股股份所对应的表决权，占公司有表决权股份总数的12.35%，不触及要约收购。本次权益变动不会导致公司控股股东及实际控制人发生变化。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"600079":"人福医药","BK0185":"二线龙头","BK0239":"医药制造","BK0012":"证金概念","BK0096":"民营医院","BK0070":"员工持股","BK0188":"融资融券","BK0028":"国家队"},"translate_title":"Renfu Pharmaceutical: Yichang Industrial Investment Group controls a total of 12.35% of the company's voting shares","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600079":1},"content_text":"格隆汇12月12日丨人福医药(600079.SH)公布，本次权益变动为公司5%以上非第一大股东宜昌产投控股集团有限公司（简称“宜昌产投集团”）全资子公司宜昌产投产业研究发展有限公司（简称“产业研究公司”）与鑫盛利保股权投资有限公司（简称“鑫盛利保”）、中国信达资产管理股份有限公司（简称“中国信达”）及宜昌高新资本投资管理有限公司（简称“宜昌高新资本”）签署《芜湖信福股权投资合伙企业（有限合伙）合伙协议》，《合伙协议》约定产业研究公司作为普通合伙人担任合伙企业的执行事务合伙人之一，与人福医药股权管理相关事项由产业研究公司决定。宜昌产投集团通过芜湖信福股权投资合伙企业（有限合伙）（简称“芜湖信福”）间接持有公司59,829,636股股份所对应的表决权，占公司有表决权股份总数的3.67%。本次权益变动后，宜昌产投集团合计控制公司201,597,643股股份所对应的表决权，占公司有表决权股份总数的12.35%，不触及要约收购。本次权益变动不会导致公司控股股东及实际控制人发生变化。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2490388358"}